IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q1 2016 Holdings

Filed 2016-05-16 | 17 holdings | $46.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corvus Pharmaceuticals Inc(CRVS)COM221015100$45.7M3,154,04698.1%
Vanguard Index FDS(VTI)TOTAL STK MKT922908769$297.4K2,837,1000.6%
Ophthotech CorpCOM683745103$207.6K4,910,4870.4%
Inogen Inc(INGN)COM45780L104$159.6K3,549,3200.3%
Vanguard Intl Equity Index F(VGK)FTSE EUROPE ETF922042874$101.9K2,101,0000.2%
Colucid Pharmaceuticals IncCOM19716T101$19.0K3,056,5630.0%
Tobira Therapeutics IncCOM88883P101$18.7K2,281,4050.0%
Acceleron Pharma Inc(XLRN)COM00434H108$17.8K673,0630.0%
Penumbra, Inc.(PEN)COM70975L107$12.1K263,1910.0%
Nabriva Therapeutics AGCOM62957M104$7.8K874,9850.0%
Invuity IncCOM46187J205$6.8K936,1930.0%
Wright MED Group N VRIGHT 03/01/2019N96617126$5.8K$4,622,0320.0%
HTG Molecular Diagnostics IncCOM40434H104$3.7K1,280,1850.0%
Spectranetics CorpCOM84760C107$3.4K236,8260.0%
Tokai Pharmaceuticals IncCOM88907J107$2.6K470,9460.0%
Glaukos Corp(GKOS)COM377322102$1.7K101,1060.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$892127,5630.0%